Pre-Conference


    • Course Directors

      Wayne (Nick) T. Nicholson, M.D., Pharm.D. & Eric T. Matey, Pharm.D., R.Ph.

      Course Description

      Pharmacogenomics (PGx), the study of how one’s genes may affect an individual’s response to medication, has reached the translational stage for various specialties in medicine. Over thirty years of research has led to promising advances in the clinical practice. Mayo Clinic experts, with experience leading the implementation of pharmacogenomics, will provide practical guidance on a range of topics.

      Learning Objectives

      Upon conclusion of this program, participants should be able to:

      • Discuss how guidelines can be used by clinicians to make specific prescribing decisions for patient care when genetic information is available.
      • Identify key principles for implementation of PGx into clinical practice
      • Provide examples of how the content of each PGx recommendation is tailored based on available evidence in various disease states including cardiac disease, cancer, psychiatry, pain and more.
      • Describe an example of preemptive testing for inpatients and outpatients
      • Outline PGx tests available for use in clinical practice

      Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.

      Intended Audience

      Pharmacists, nurses, physicians, nurse practitioners, physician assistants, genetic counselors and any other members of the patient care team.

      Location

      Course headquarters will be located at the Mayo Clinic Gonda Building on the 19th floor, 100 Second Avenue Southwest, Rochester, Minnesota. Meeting facilities are easily accessible by skyway and pedestrian subway, which connect Mayo Clinic to shops, restaurants, and hotels.

      Credit

      Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Mayo Clinic College of Medicine designates this activity/internet point-of-care activity for a maximum of 11.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      ACPE LogoACPE: Mayo Clinic College of Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to a maximum of 11.5 knowledge based contact hours. Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

      Visit the activity’s website for additional information regarding the ACPE credit offering.

      Other Health Care Professionals - A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

      Register Online

      The registration fee includes tuition, continental breakfast, and break refreshments. Seating is limited, therefore, early registration is advised. A confirmation is provided upon receipt of payment. Please present the confirmation letter when checking in at the meeting registration desk.

      $295 USD Also attending the Individualizing Medicine Conference
      $345 USD Not attending the Individualizing Medicine Conference

      PGx Testing Available

      $120 USD Discounted Pharmacogenomic (PGx) Testing (optional)

      This conference is providing the opportunity to have Pharmacogenomic testing at a discounted fee, to aid in the educational experience. The OneOme RightMed® pharmacogenomic test offering is a one-time offer of a single test kit at a discounted fee of $120 and needs to be ordered through a medical care provider.

      Lodging Accommodations

      Discounted guest room rates are available at a select number of downtown Rochester hotels. In order to receive the special rate, reservations must be made before the room block is filled or before the expiration date of September 18th, 2017, whichever comes first. Specific hotel information available on the Lodging section of the location page.

    • Saturday, October 7th, 2017

    • 12:00 PM

      Registration and Refreshments

    • 12:30 PM

      Introductions & Welcome

    • Pharmacogenomics: From Bench to Bedside Part I

    • 12:40 PM

      Pharmacogenomics Update (PGx)
      Richard Weinshilboum, M.D.

    • 1:10 PM

      Q&A

    • 1:20 PM

      Pharmacogenomics from the Lab Medicine Perspective
      Ann M. Moyer, M.D., Ph.D.

    • 1:50 PM

      Q&A

    • 2:00 PM

      Break

    • 2:15 PM

      How to Interpret the PGx Report
      Eric Matey, Pharm.D., R.Ph.

    • Pharmacogenomics: From Bench to Bedside Part I

    • 2:45 PM

      Q&A

    • 2:55 PM

      HLA(Gout)/Predictive/Preventive
      Christine Formea, Pharm.D., R.Ph.

    • 3:55 PM

      Gastroenterology
      Jo Giri, M.D.

    • 5:00 PM

      Closing Comments and Adjourn

    • Sunday, October 8th, 2017

    • 8:00 AM

      Welcome and Review

    • Pharmacogenomics: From Bench to Bedside Part II

    • 8:15 AM

      Systems & Tools for Implementation
      Wayne (Nick) T. Nicholson, M.D., Ph.D.

    • 8:00 AM

      Q&A

    • 9:05 AM

      Research in Pharmacogenomics
      Leiwei Wang, M.D., Ph.D.

    • 9:35 AM

      Q&A

    • 8:00 AM

      Break

    • Clinical Case Applications in Pharmacogenomics Part II

    • 10:00 AM

      Cardiology
      Fadi E. Shamoun, M.D.

    • 11:00 AM

      HIV
      John D. Zeuli, Pharm.D., R.Ph.

    • 12:00 PM

      Luncheon

    • Clinical Case Applications in Pharmacogenomics Part III

    • 1:00 PM

      Cancer/TPMT
      Richard Weinshilboum, M.D.

    • 2:00 PM

      Pain
      Wayne (Nick) T. Nicholson, M.D., Ph.D.

    • 3:00 PM

      Break

    • Clinical Case Applications in Pharmacogenomics Part IV

    • 3:15 PM

      Transplant
      Christopher B. Grilli, Pharm.D., R.Ph.

    • 4:15 PM

      Psych
      Adrijana Kekic, Pharm.D.

    • 5:15 PM

      Closing Comments and Adjourn


  • Course Description

    This session will highlight the use of specialized testing (including NGS) in the diagnosis and/or treatment of patients with brain tumors and hematologic malignancies. Case presentations will include discussion by both laboratory and clinical experts.

    Case Discussion Includes:

    • Neuro-Oncology with Drs. Robert B. Jenkins and Daniel Honore Lachance
    • Hematology with Drs. Rong He and Aref Al-Kali

  • Course Description

    Clinical genetic and genomic testing is becoming increasingly informative for determining the diagnosis, prognosis, disease risk, and optimal therapeutic strategies for patients. The genetic and genomic testing repertoire is diverse, varying by the underlying testing methodology and the type of variants detected, the scale of the test (single gene/variant to genome-wide), as well as the intent of the test. The results of this testing are complex, often accompanied by uncertainty, and may impact patients throughout their lives. Thus, the appropriate interpretation, communication, and management of results is paramount to optimizing patient care.

    This session brings together experts in the fields of Clinical Genomics, Oncology, Pharmacogenomics, and Genetic Counseling to guide the audience through complexities of genetic and genomic testing.

    Learning Objectives

    Upon conclusion of this program, participants should be able to:

    • Identify the uncertainty and challenges inherent in clinical genetic and genomic testing in the clinical practice
    • Discuss the strategies for interpretation of clinical genetic and genomic testing results
    • Provide important considerations for the counseling of patients and families receiving genetic or genomic results
    • Discuss the management of patient results to maximize appropriate use and actionability now and in the future

Post-Conference
Wednesday, October 11, 8:00 AM - 12:00 PM
Mayo Civic Center, 30 Civic Center Drive, SW, Rochester, MN


    • For faculty details, view the full program and speaker information online.

      The goal of this session is to highlight the implementation of Cardiovascular Genomics in the various clinics through Mayo Clinic and their integration into the CV genomics program.

    • 7:00 AM

      Continental Breakfast and Registration

    • 8:00 AM

      Welcome and Introduction to the Mayo Cardiovascular Genomics Program

    • 8:30 AM

      The Cardiac Channelopathies: Who Needs an ICD?

    • 9:00 AM

      Hypertrophic Cardiomyopathy: Who Needs Intervention/ICD

    • 9:30 AM

      Aortopathy Genotype and When to Cut

    • 10:00 AM

      Break

    • 10:20 AM

      Recent Genetic Insights into Dilated Cardiomyopathy

    • 10:50 AM

      Genetic Implications of Familial Hypercholesterolemia

    • 11:20 AM

      Panel Discussion: Bringing it all Together

    • 12:00 PM

      Adjourn

  • Clinical genetic and genomic testing is becoming increasingly informative for determining the diagnosis, prognosis, disease risk, and optimal therapeutic strategies for patients. The genetic and genomic testing repertoire is diverse, varying by the underlying testing methodology and the type of variants detected, the scale of the test (single gene/variant to genome-wide), as well as the intent of the test. The results of this testing are complex, often accompanied by uncertainty, and may impact patients throughout their lives. Thus, the appropriate interpretation, communication, and management of results is paramount to optimizing patient care.

    This session brings together experts in the fields of Clinical Genomics, Oncology, Pharmacogenomics, and Genetic Counseling to guide the audience through complexities of genetic and genomic testing.

    Learning Objectives:

    • Identify the uncertainty and challenges inherent in clinical genetic and genomic testing in the clinical practice
    • Discuss the strategies for interpretation of clinical genetic and genomic testing result
    • Provide important considerations for the counseling of patients and families receiving genetic or genomic results
    • Discuss the management of patient results to maximize appropriate use and actionability now and in the future
  • For faculty details, view the full program and speaker information online.


    • 7:00 AM

      Continental Breakfast and Registration

    • 8:00 AM

      Welcome and Introduction
      Konstantinos Lazaridis, M.D.

    • 8:15 AM

      Precision Medicine in Action: Inflammatory Bowel Diseases in Young Children.
      Michael C. Stephens, M.D.

    • 8:45 AM

      The Importance of Genetic Counseling in Genomic Medicine
      Teresa M. Kruisselbrink, M.S., CGC

    • 9:15 AM

      Diagnosis of Idiopathic Liver Disease in Children Using Genomic Methods
      Mounif El-Youssef, M.D.

    • 9:45 AM

      Panel Discussion and Q&A
      Teresa Kruisselbrink, MS, CGC, Konstantinos Lazaridis, M.D., Mounif El-Youssef, M.D. & Michael C. Stephens, M.D.

    • 10:00 AM

      Break

    • 10:30 AM

      Metabolic Liver Disease in the Era of Individualized Medicine
      Brendan Lanpher, M.D.

    • 11:00 AM

      Applying Genomics for Better Understanding Young Onset Colorectal Cancer of Patients Seen in Medical Practice
      Lisa Boardman, M.D.

    • 11:30 AM

      Endoscopic Ultrasound Facilitates a Theranostic Management Approach for Gastrointestinal Stromal Tumors (GISTs) and Pancreas Cancer
      Ferga C. Gleeson, M.B.,B.Ch.

    • 12:00 PM

      Panel Discussion
      Lisa Boardman, M.D., Ferga C. Gleeson, M.B.,B.Ch., Brendan Lanpher, M.D., Douglas L. Riegert-Johnson, M.D., & N. Jewel Samadder, M.D.

    • 12:30 PM

      Adjourn

Sign Up for Updates Receive information about our 2017 conference speakers, schedule and registration.

Contact For more information about Individualizing Medicine 2017:
Advancing Care Through Genomics, contact: Caer Rohrer Vitek - Phone: 507-284-1499 - Email: imconference@mayo.edu

Give Hope

The Center for Individualized Medicine is a strategic priority for the Campaign for Mayo Clinic.